Home  >  News
  EMA committee recommends approval of Bristol-Myers Squibb's Opdivo plus low-dose Yervoy as first-line treatment for RCC,   November 16, 2018
  Glenmark pharmaceuticals announces new data presentations on Ryaltris at ACAAI Annual Scientific Meeting 2018,   November 16, 2018
  OncoStem receives accreditation from College of American Pathologists,   November 16, 2018
  Meril Life Sciences receives approval for Myval-TAVR Technology,   November 16, 2018
  Phebra establishes UK subsidiary to expand international operations,   November 16, 2018
  New Technique developed by Indian doctors to improve treatment of Ptosis,   November 16, 2018
  HealthFin adjudged as the Best Start-up in healthcare sector at the Navbharat Healthcare Summit & Awards 2018,   November 16, 2018
  Eli Lilly seeks US FDA approval for Lasmiditan for acute treatment of migraine,   November 16, 2018
  Discovery suggests new route to fight infection, disease,   November 16, 2018
  Aurobindo Pharma net dips by 22% in Q2 to Rs. 611 cr, interim dividend of 125%,   November 16, 2018
  Planmed & Disior ink collaboration and distribution pact,   November 16, 2018
  Glenmark Pharma receives US FDA approval for generic Aubagio tablets,   November 16, 2018
  Seattle initiates phase 1 trial of SEA-BCMA for relapsed or refractory MM,   November 16, 2018
  NIPER SAS Nagar 6th biennial international conference kicks off with focus on drug discovery from natural products,   November 16, 2018
  Healthians gears up to hire 1,500 employees of phlebotomists, lab technicians and specialised wellness consultants,   November 16, 2018
  Certara receives two new dermal virtual bioequivalence grants from US FDA,   November 16, 2018
  Impact of GST has largely been positive and constructive on pharma sector: Mansukh Mandaviya,   November 16, 2018
  Ipsen receives European approval for Cabometyx to treat HCC in adults previously treated with sorafenib,   November 16, 2018
  Biohaven begins phase 3 trial evaluating rimegepant as preventive therapy for migraine,   November 16, 2018
  NeuroVive gets SEK 1.5 mn Vinnova funding to support development of NV354 to treat genetic mitochondrial disorders,   November 16, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |